eKLIPse: a sensitive tool for the detection and quantification of mitochondrial DNA deletions from next-generation sequencing data.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
06 2019
Historique:
received: 23 08 2018
accepted: 17 10 2018
pubmed: 6 11 2018
medline: 14 2 2020
entrez: 6 11 2018
Statut: ppublish

Résumé

Accurate detection of mitochondrial DNA (mtDNA) alterations is essential for the diagnosis of mitochondrial diseases. The development of high-throughput sequencing technologies has enhanced the detection sensitivity of mtDNA pathogenic variants, but the detection of mtDNA rearrangements, especially multiple deletions, is still poorly processed. Here, we present eKLIPse, a sensitive and specific tool allowing the detection and quantification of large mtDNA rearrangements from single and paired-end sequencing data. The methodology was first validated using a set of simulated data to assess the detection sensitivity and specificity, and second with a series of sequencing data from mitochondrial disease patients carrying either single or multiple deletions, related to pathogenic variants in nuclear genes involved in mtDNA maintenance. eKLIPse provides the precise breakpoint positions and the cumulated percentage of mtDNA rearrangements at a given gene location with a detection sensitivity lower than 0.5% mutant. eKLIPse software is available either as a script to be integrated in a bioinformatics pipeline, or as user-friendly graphical interface to visualize the results through a Circos representation ( https://github.com/dooguypapua/eKLIPse ). Thus, eKLIPse represents a useful resource to study the causes and consequences of mtDNA rearrangements, for further genotype/phenotype correlations in mitochondrial disorders.

Identifiants

pubmed: 30393377
doi: 10.1038/s41436-018-0350-8
pii: S1098-3600(21)01662-2
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1407-1416

Auteurs

David Goudenège (D)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
Biochemistry and Genetics Department, Angers Hospital, Angers, France.

Celine Bris (C)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
Biochemistry and Genetics Department, Angers Hospital, Angers, France.

Virginie Hoffmann (V)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.

Valerie Desquiret-Dumas (V)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
Biochemistry and Genetics Department, Angers Hospital, Angers, France.

Claude Jardel (C)

Biochemistry Department and Genetics Center, APHP, GHU Pitié-Salpêtrière, Paris, France.

Benoit Rucheton (B)

Biochemistry Department and Genetics Center, APHP, GHU Pitié-Salpêtrière, Paris, France.

Sylvie Bannwarth (S)

Université Côte d'Azur, CHU de Nice, INSERM, CNRS, IRCAN, Nice, France.

Veronique Paquis-Flucklinger (V)

Université Côte d'Azur, CHU de Nice, INSERM, CNRS, IRCAN, Nice, France.

Anne Sophie Lebre (AS)

CHU Reims, Hôpital Maison Blanche, Pole de biologie, Service de génétique, Reims, France.

Estelle Colin (E)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
Biochemistry and Genetics Department, Angers Hospital, Angers, France.

Patrizia Amati-Bonneau (P)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
Biochemistry and Genetics Department, Angers Hospital, Angers, France.

Dominique Bonneau (D)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
Biochemistry and Genetics Department, Angers Hospital, Angers, France.

Pascal Reynier (P)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.
Biochemistry and Genetics Department, Angers Hospital, Angers, France.

Guy Lenaers (G)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France.

Vincent Procaccio (V)

MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University, Angers, France. ViProcaccio@chu-angers.fr.
Biochemistry and Genetics Department, Angers Hospital, Angers, France. ViProcaccio@chu-angers.fr.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH